Filter Results
:
(13,715)
Show Results For
-
All HBS Web
(13,715)
- People (49)
- News (3,434)
- Research (7,379)
- Events (54)
- Multimedia (113)
- Faculty Publications (4,876)
Show Results For
-
All HBS Web
(13,715)
- People (49)
- News (3,434)
- Research (7,379)
- Events (54)
- Multimedia (113)
- Faculty Publications (4,876)
- May 2019 (Revised September 2019)
- Case
Mobike and ofo: Dancing with Titans (A)
By: Shikhar Ghosh and Haibo Zhao
This case address pacing issues – how fast does a company need to scale? It also examines the role of investors in determining company strategy and exit.
Mobike and ofo were two dominant players in China’s emerging dockless bike-sharing market, that allowed users... View Details
Mobike and ofo were two dominant players in China’s emerging dockless bike-sharing market, that allowed users... View Details
Keywords:
Information Technology;
Venture Capital;
Financing and Loans;
Competition;
Value Creation;
Governance;
Economics;
Business Startups;
Strategy;
Business Exit or Shutdown;
Entrepreneurship;
Infrastructure;
Transportation;
Bicycle Transportation;
China
Ghosh, Shikhar, and Haibo Zhao. "Mobike and ofo: Dancing with Titans (A)." Harvard Business School Case 819-135, May 2019. (Revised September 2019.)
- 2016
- Teaching Note
Advanced Leadership Pathways: Raymond Jetson's MetroMorphosis and the Effort to Transform Baton Rouge
By: Rosabeth M. Kanter, Tessa Natanay Hamilton and Ai-Ling Jamila Malone
Teaching Note for Case 315-057. Building on his successes as a politician and preacher in Baton Rouge, Louisiana, Rev. Raymond Jetson sought to empower Baton Rouge citizens to innovate solutions for their community challenges. After stepping down as the head of the...
View Details
Keywords:
Social Entrepreneurship;
Nonprofit Organizations;
Business and Community Relations;
Problems and Challenges;
Leadership;
Louisiana;
Baton Rouge
Kanter, Rosabeth M., Tessa Natanay Hamilton, and Ai-Ling Jamila Malone. "Advanced Leadership Pathways: Raymond Jetson's MetroMorphosis and the Effort to Transform Baton Rouge." Harvard Business Publishing Teaching Note 316-033, 2016.
- January 2020
- Case
Freelancer, Ltd.
By: Christopher Stanton, Karim R. Lakhani, Jennifer L. Hoffman, Jin Hyun Paik and Nina Cohodes
Over the course of the 2010s, the rapid advancement of mobile technologies and the rise of online freelancing platforms seemed to portend a radical transformation of labor markets into on-demand, flexible talent pools. Even though several Fortune 500...
View Details
Keywords:
Freelancers;
Platforms;
Digital Labor;
Labor;
Human Resources;
Management;
Internet and the Web;
Growth and Development Strategy;
Digital Platforms;
Information Industry;
Australia;
United States;
Philippines
Stanton, Christopher, Karim R. Lakhani, Jennifer L. Hoffman, Jin Hyun Paik, and Nina Cohodes. "Freelancer, Ltd." Harvard Business School Case 820-075, January 2020.
- 2022
- Chapter
Connecter les rêves
By: Hubert Joly and Mariana Arnaut
Trouver du sens dans son travail est plus que jamais vécu comme essentiel. L’entreprise, l’une des organisations humaines les plus capables d’innovation, a un rôle central à jouer face aux enjeux sociaux et environnementaux. Reste à déterminer quels principes peuvent...
View Details
Joly, Hubert, and Mariana Arnaut. "Connecter les rêves." Chap. 8 in En quête de sens: Un dialogue entre dirigeants et futurs dirigeants [In Search of Meaning: A Dialogue Between Leaders and Future Leaders], edited by Rodolphe Durand and Cécile Lavrard-Meyer de Lisle, 125–142. Paris: Dunod, 2022, French ed.
- 2007
- Article
Pharmacovigilance and the Missing Denominator: The Changing Context of Pharmaceutical Risk Mitigation
By: Arthur A. Daemmrich
In the wake of Vioxx, Avandia, and other recent prominent cases of drugs found to cause side effects after marketing, the safety of pharmaceuticals has come to the forefront of American public policy. Press attention, congressional investigations, and legislative...
View Details
Keywords:
Brands and Branding;
Policy;
Risk Management;
Government Legislation;
Risk and Uncertainty;
Goals and Objectives;
Customers;
Pharmaceutical Industry;
Health Industry;
United States
Daemmrich, Arthur A. "Pharmacovigilance and the Missing Denominator: The Changing Context of Pharmaceutical Risk Mitigation." Pharmacy in History 49, no. 2 (2007): 61–75.
- 10 Jul 2015
- Blog Post
Can Entrepreneurship Be Taught?
Professor Jeffrey Bussgang has played a critical role in expanding Harvard Business School’s entrepreneurial offerings over the last few years. A...
View Details
- 20 Mar 2007
- First Look
First Look: March 20, 2007
included her husband. A decade later, in 1986, Claiborne was CEO of her own Fortune 500 company, reaching that milestone faster than any other business up to that point View Details
Keywords:
Martha Lagace
- 31 Jan 2024
- Blog Post
Career Advice from the Guests of the HBS Climate Rising Podcast
episodes with the question: What advice do you have for people considering a career in business and climate change? Below is a distillation of...
View Details
- 10 Aug 2010
- First Look
First Look: August 10
Frank V. Cespedes, and Kerry HermanHarvard Business School Case 709-441 In 2008, concert producer and promoter Live Nation faces a decision about its strategy View Details
Keywords:
Martha Lagace
- June 2020
- Teaching Note
Shiseido Acquires Drunk Elephant
By: Jill Avery
On October 7, 2019, the Shiseido Group announced that it would acquire clean skincare brand Drunk Elephant for $845 million, a valuation of 8.5 times sales. Did Shiseido pay too much or too little for this brand asset? How much was the Drunk Elephant brand worth and...
View Details
Keywords:
Brand Management;
Brand Valuation;
Brand Equity;
Brand Value;
Mergers & Acquisitions;
Startup;
DTC;
Brand Portfolio Strategy;
Marketing;
Marketing Strategy;
Brands and Branding;
Mergers and Acquisitions;
Valuation;
Entrepreneurship;
Business Startups;
Beauty and Cosmetics Industry;
Consumer Products Industry;
United States;
Japan;
Asia;
North America
- 20 Aug 2024
- Book
Why Competing With Tech Giants Requires Finding Your Own Edge
strategies. Hence, this transition necessitates a paradigm shift in strategic thinking. Flip the perspective: Your ecosystem, tech giants included Often, traditional businesses...
View Details
- May 2010
- Column
Block-by-Blockbuster Innovation
Executives often find themselves debating the merits of incremental innovations versus game-changers, but that's a false dichotomy, says HBR columnist Rosabeth Moss Kanter. Even if a company is lucky enough to come up with the next Kindle, Swiffer, or smartphone,...
View Details
Keywords:
Innovation and Management;
Resource Allocation;
Product;
Business Processes;
Risk and Uncertainty
Kanter, Rosabeth Moss. "Block-by-Blockbuster Innovation." Harvard Business Review 88, no. 5 (May 2010): 38.
- June 2005 (Revised April 2008)
- Case
Whole Foods Market, Inc.
By: John R. Wells and Travis Haglock
Can a short-sleeved, sandal-wearing, college dropout create a company manifesting love, joy, and happiness? Chainsaw John Mackey did. This CEO took a five-month sabbatical to hike the Appalachian Trail. More credentials: Sales-per-square foot of $690 and rising. Hiring...
View Details
Keywords:
Management Style;
Motivation and Incentives;
Food;
Management Practices and Processes;
Groups and Teams;
Success;
Leadership Style;
Management Teams;
Business Growth and Maturation;
Emerging Markets;
Retail Industry;
Food and Beverage Industry;
Consumer Products Industry
Wells, John R., and Travis Haglock. "Whole Foods Market, Inc." Harvard Business School Case 705-476, June 2005. (Revised April 2008.)
- 21 Jan 2014
- First Look
First Look: January 21
databases, search tools, and other programs-that would help the company reach scale. Purchase this case: http://hbr.org/product/claritas-genomics/an/814032-PDF-ENG Harvard Business School Case 514-018 Olam: View Details
Keywords:
Sean Silverthorne
- June 2006 (Revised April 2007)
- Case
BioScale
By: H. Kent Bowen and Bradley R. Staats
In 2004, Mark Lundstrom must decide on a funding method and strategic approach for BioScale, a biotechnology company that he founded. BioScale has developed a microchip-based bioanalytical platform that can be used to detect very small concentrations of cells, viruses,...
View Details
Keywords:
Entrepreneurship;
Science-Based Business;
Capital;
Financing and Loans;
Partners and Partnerships;
Biotechnology Industry
Bowen, H. Kent, and Bradley R. Staats. "BioScale." Harvard Business School Case 606-100, June 2006. (Revised April 2007.)
- February 2009 (Revised December 2009)
- Case
Merck: Global Health and Access to Medicines
By: V. Kasturi Rangan and Katharine Lee
The case describes the effort of Merck, a global leader in pharmaceuticals, in making available its medicines to the poor. The challenge for the company (or for that matter, any pharmaceutical company) is how to integrate its business strategy with its corporate social...
View Details
Keywords:
Globalized Firms and Management;
Health Care and Treatment;
Emerging Markets;
Corporate Social Responsibility and Impact;
Poverty;
Business Strategy;
Pharmaceutical Industry
Rangan, V. Kasturi, and Katharine Lee. "Merck: Global Health and Access to Medicines." Harvard Business School Case 509-048, February 2009. (Revised December 2009.)
- March 2008 (Revised October 2009)
- Case
Crossing Borders: MTC's Journey through Africa
By: Tarun Khanna and Ayesha Khan
This is the story of MTC, a Kuwaiti telecom company that has grown from a sleepy, state monopoly to become one of the fastest growing telecom companies in the world, with the largest regional footprint across the Middle East and Africa. The CEO of the company, Dr. Saad...
View Details
Keywords:
Mergers and Acquisitions;
Cross-Cultural and Cross-Border Issues;
Global Strategy;
Globalized Firms and Management;
Growth and Development Strategy;
Emerging Markets;
Telecommunications Industry;
Africa;
Kuwait
Khanna, Tarun, and Ayesha Khan. "Crossing Borders: MTC's Journey through Africa." Harvard Business School Case 708-477, March 2008. (Revised October 2009.)
- January 2006 (Revised October 2007)
- Background Note
Managing Networked Businesses: Course Overview for Students
Provides an overview for students of the MBA elective course Managing Networked Businesses (MNB). MNB focuses on management challenges in businesses that exhibit network effects. The first section of the note explains that such businesses comprise a large and growing...
View Details
Keywords:
Business Model;
Capital Structure;
Business or Company Management;
Network Effects;
Organizational Design;
Business and Government Relations;
Social and Collaborative Networks;
Competitive Strategy
Eisenmann, Thomas R. "Managing Networked Businesses: Course Overview for Students." Harvard Business School Background Note 806-103, January 2006. (Revised October 2007.)
- March 2011
- Article
What Do Dividends Tell Us About Earnings Quality
By: Douglas Skinner and Eugene F. Soltes
Over the past 30 years, there have been significant changes in the distribution of earnings (cross-sectional variation has increased, with increasing left skewness) as well as in corporate payout policy, with many fewer firms paying dividends and the emergence of stock...
View Details
Keywords:
Distribution;
Business Earnings;
Change;
Policy;
Stocks;
Investment Return;
Performance Consistency;
Quality
Skinner, Douglas, and Eugene F. Soltes. "What Do Dividends Tell Us About Earnings Quality." Review of Accounting Studies 16, no. 1 (March 2011).
- 2008
- Chapter
Where is the Pharmacy to the World? Pharmaceutical Industry Location and International Regulatory Variation
By: Arthur A. Daemmrich
A consumer-oriented model for drug development and use has attracted attention in recent years as an alternative to the much-maligned approach of mass-marketing blockbuster drugs. In a parallel development, patients and disease-based organizations have assumed greater...
View Details
Keywords:
Geographic Location;
Governing Rules, Regulations, and Reforms;
Health Testing and Trials;
Demand and Consumers;
Pharmaceutical Industry;
European Union;
Germany;
United States
Daemmrich, Arthur A. "Where is the Pharmacy to the World? Pharmaceutical Industry Location and International Regulatory Variation." Chap. 16 in Ways of Regulating: Therapeutic Agents between Plants, Shops, and Consulting Rooms. Vol. 363, edited by Jean Paul Gaudillière and Volker Hess, 271–290. Berlin, Germany: Max-Planck-Institut für Wissenschaftsgeschichte, 2008.